NIH-funded study found higher dose of DHA associated with lower early preterm birth rate
On May 24, 2021, scientists reported that women taking 1,000 mg of docosohexanoic acid (DHA) daily in the…
Labcorp study suggested COVID-19 antibodies remain at least 10 months after infection
On May 24, 2021, LabCorp reported that nearly 87% of naturally infected COVID-19 patients maintained antibodies to SARS-CoV-2…
Study initiated exploring coadministration of 20-valent pneumococcal conjugate vaccine with third dose of Pfizer-BioNTech COVID-19 vaccine
On May 24, 2021, Pfizer announced that the first enrolled subjects had received their immunizations as part of…
AstraZeneca COVID-19 vaccine Vaxzevria authorised for emergency use in Japan
On May 21, 2021, AstraZeneca announced that it had been granted a special approval for emergency use in…
G20 leaders boosted support of the Access to COVID-19 Tools Accelerator
On May 21, 2021, world leaders the Global Health Summit adopted an agenda to overcome the COVID-19 pandemic,…
EMA issued positive scientific opinion on GSK and Vir Biotechnologyﾒs sotrovimab for the early treatment of COVID-19
On May 21, 2021, GlaxoSmithKline and Vir Biotechnology announced that the European Medicines Agencyﾒs (EMA) Committee for Human…
Gavi signed agreement with Johnson & Johnson for supply of its COVID-19 vaccine to COVAX
On May 21, 2021, Gavi, the Vaccine Alliance, that it had signed an advance purchase agreement with Johnson…
Merck announced positive topline results from phase 3 pediatric studies for investigational 15-valent pneumococcal conjugate vaccine
On May 20, 2021, Merck announced V114, the company�s investigational 15-valent pneumococcal conjugate vaccine, met its primary immunogenicity…
XPhyto rapid point-of-care COVID-19 PCR test offered for sale in Germany
On May 20, 2021, XPhyto announced that its distribution, storage and logistics partner, Max Pharm has begun the…
Brazilian HRA authorized Sorrento phase 2 pivotal clinical trial of COVI-MSCﾙ in hospitalized COVID-19 patients with ARDS
On May 20, 2021, Sorrento Therapeutics announced receipt of clearance from the Brazilian regulatory agency (ANVISA) to proceed…
Biotechnology | COVID-19 | Life Science History | Life Science News | Pharmaceutical | Therapeutics | Vaccine
Pfizer and BioNTech announced supplying EU with up to 1.8 billion additional doses of COMIRNATY
On May 20, 2021, Pfizer and BioNTech announced a new agreement with the European Commission (EC) to supply…
Pfizer and BioNTech signed agreement to supply 60 million additional doses of their COVID-19 vaccine to Turkey
On May 20, 2021, Pfizer and BioNTech announced an agreement with Turkeyﾒs Ministry of Health to supply 60…
APEIRON Biologics’ APN01 selected for large-scale U.S. trial in COVID-19
On May 19, 2021, APEIRON Biologics announced the next development steps for APN01 (alunacedase alfa) for the treatment…
Thermo Fisher and University of California, San Francisco announced cell therapy cGMP manufacturing and collaboration center
On May 19, 2021, Thermo Fisher Scientific and the University of California, San Francisco (UCSF) announced they have…
Medicago and GSK announced positive interim Phase 2 results for adjuvanted COVID-19 vaccine candidate
On May 18, 2021, GlaxoSmithKline and Medicago reported positive interim Phase 2 clinical trial safety and immunogenicity data…
Resilience received USD $164 million from Government of Canada to modernize and expand Its Ontario biomanufacturing site
On May 18, 2021, National Resilience announced that the Government of Canada will invest CAD 199.2 million ($163.8…
Oxford University and Oracle partnered to speed identification of COVID-19 variants
On May 17, 2021, Oxford University and Oracle announced they had created a Global Pathogen Analysis System combining…
Sanofi and GSK COVID-19 vaccine candidate demonstrated strong immune responses across all adult age groups in Phase 2 trial
On May 17, 2021, Sanofi and GSK reported that their adjuvanted recombinant COVID-19 vaccine candidate achieved strong rates…
Oxford University and Oracle Partner to speed identification of COVID-19 variants
On May 17, 2021, Oxford University and Oracle have created a Global Pathogen Analysis System (GPAS) combining Oxfordﾒs…
Preliminary data suggested mixing Covid-19 vaccine increases reactogenicity
On May 13, 2021, University of Oxford researchers reported that Com-COV study data comparing mixed dosing schedules of…
Brain computer interface turned mental handwriting into text on screen
On May 12, 2021, HHMI researchers have, for the first time, decoded the neural signals associated with writing…
The ALS Society of BC awarded $2 million for PROJECT HOPE to establish ALS research professorship at UBC
On May 12, 2021, the province of British Columbia provided the ALS Society of BC with $2 million…
INOVIO’s Pan-COVID-19 vaccine candidate (INO-4802) induces broad immunity against vviral variants in preclinical studies
On May 12, 2021, Inovio Pharma announced that its next-generation Pan-COVID-19 vaccine candidate, INO-4802, induced potent neutralizing antibodies…
Dr. Connie Eaves was inducted into The Royal Society for her development of robust functional methods to quantify and characterize distinct types of primitive blood and mammary cell precursors.
On May 11, 2011, University of British Columbia professor Connie Eaves was inducted into The Royal Society for…
Gene therapy restored immune function in children with rare immunodeficiency
On May 10, 2021, the National Institutes of Health reported that an investigational gene therapy can safely restore…
Altimmune announced preclinical data for AdCOVIDﾙ demonstrating sterilizing immunity after single intranasal dose
On May 10, 2021, Altimmune announced positive results from a preclinical study of AdCOVID in a SARS-CoV-2 challenge…
FDA granted Fast Track Designation to CERC-002 for treatment of hospitalized patients with COVID-19
On May 10, 2021, Cerecor announced that the U.S. Food and Drug Administration (FDA) had granted Fast Track…
Pfizer and BioNTech received first U.S. EUA of COVID-19 vaccine in adolescents
On May 10, 2021, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) had expanded…
GSK and Vir Biotechnology announced start of the EMA rolling review of VIR-7831 (sotrovimab) for early treatment of COVID-19
On May 7, 2021, GlaxoSmithKline and Vir Biotechnology announced that the European Medicines Agency (EMA) has started a…
Pfizer and BioNTech announced supplying COVID-19 vaccine for Olympic athletes at 2020 Tokyo games
On May 6, 2021, Pfizer announced the signing of a Memorandum of Understanding (MoU) with the International Olympic…